Phentermine
- TRADE NAMES: Adipex-P (Teva); Behapront; Diminex; Ionamin (Celltech); Lomaira (Avanthi); Minobese-Forte; Panbesy; Panbesyl; Qsymia (Vivus); Redusa; Suprenza; Umine; Zantryl
- INDICATIONS: Obesity
- CLASS: Amphetamine
- HALF-LIFE: 19–24 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Fluoxetine, Fluvoxamine, MAO inhibitors, Paroxetine Hydrochloride, Phenelzine, Sertraline, Tranylcypromine
PREGNANCY CATEGORY: X
Qsymia is phentermine and topiramate.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric